Literature DB >> 25320085

KRIT1 protein depletion modifies endothelial cell behavior via increased vascular endothelial growth factor (VEGF) signaling.

Peter V DiStefano1, Julia M Kuebel1, Ingrid H Sarelius1, Angela J Glading2.   

Abstract

Disruption of endothelial cell-cell contact is a key event in many cardiovascular diseases and a characteristic of pathologically activated vascular endothelium. The CCM (cerebral cavernous malformation) family of proteins (KRIT1 (Krev-interaction trapped 1), PDCD10, and CCM2) are critical regulators of endothelial cell-cell contact and vascular homeostasis. Here we show novel regulation of vascular endothelial growth factor (VEGF) signaling in KRIT1-depleted endothelial cells. Loss of KRIT1 and PDCD10, but not CCM2, increases nuclear β-catenin signaling and up-regulates VEGF-A protein expression. In KRIT1-depleted cells, increased VEGF-A levels led to increased VEGF receptor 2 (VEGFR2) activation and subsequent alteration of cytoskeletal organization, migration, and barrier function and to in vivo endothelial permeability in KRIT1-deficient animals. VEGFR2 activation also increases β-catenin phosphorylation but is only partially responsible for KRIT1 depletion-dependent disruption of cell-cell contacts. Thus, VEGF signaling contributes to modifying endothelial function in KRIT1-deficient cells and microvessel permeability in Krit1(+/-) mice; however, VEGF signaling is likely not the only contributor to disrupted endothelial cell-cell contacts in the absence of KRIT1.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Adherens Junction; CCM; Krit1; Permeability; Phosphotyrosine Signaling; Vascular Endothelial Growth Factor (VEGF); β-Catenin (B-Catenin)

Mesh:

Substances:

Year:  2014        PMID: 25320085      PMCID: PMC4239650          DOI: 10.1074/jbc.M114.582304

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways.

Authors:  B K Lal; S Varma; P J Pappas; R W Hobson; W N Durán
Journal:  Microvasc Res       Date:  2001-11       Impact factor: 3.514

2.  Regulation of E-cadherin/Catenin association by tyrosine phosphorylation.

Authors:  S Roura; S Miravet; J Piedra; A García de Herreros; M Duñach
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

3.  Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively.

Authors:  H Zeng; S Sanyal; D Mukhopadhyay
Journal:  J Biol Chem       Date:  2001-07-02       Impact factor: 5.157

4.  Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1).

Authors:  T Sahoo; E W Johnson; J W Thomas; P M Kuehl; T L Jones; C G Dokken; J W Touchman; C J Gallione; S Q Lee-Lin; B Kosofsky; J H Kurth; D N Louis; G Mettler; L Morrison; A Gil-Nagel; S S Rich; J M Zabramski; M S Boguski; E D Green; D A Marchuk
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

5.  Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun.

Authors:  Roger G Fahmy; Alla Waldman; Guishui Zhang; Ainslie Mitchell; Nicodemus Tedla; Hong Cai; Carolyn R Geczy; Colin N Chesterman; Michael Perry; Levon M Khachigian
Journal:  Nat Biotechnol       Date:  2006-07-02       Impact factor: 54.908

6.  Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations.

Authors:  R E Clatterbuck; C G Eberhart; B J Crain; D Rigamonti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

7.  Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization.

Authors:  K Spilsbury; K L Garrett; W Y Shen; I J Constable; P E Rakoczy
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

8.  Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro.

Authors:  Geerten P van Nieuw Amerongen; Pieter Koolwijk; Amanda Versteilen; Victor W M van Hinsbergh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-01       Impact factor: 8.311

9.  The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin.

Authors:  A H Huber; W I Weis
Journal:  Cell       Date:  2001-05-04       Impact factor: 41.582

10.  p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction.

Authors:  Jose Piedra; Susana Miravet; Julio Castaño; Héctor G Pálmer; Nora Heisterkamp; Antonio García de Herreros; Mireia Duñach
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

View more
  27 in total

Review 1.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

2.  Serine phosphorylation of the small phosphoprotein ICAP1 inhibits its nuclear accumulation.

Authors:  Valerie L Su; Bertrand Simon; Kyle M Draheim; David A Calderwood
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

3.  Update on Novel CCM Gene Mutations in Patients with Cerebral Cavernous Malformations.

Authors:  Concetta Scimone; Placido Bramanti; Concetta Alafaci; Francesca Granata; Francesco Piva; Carmela Rinaldi; Luigi Donato; Federica Greco; Antonina Sidoti; Rosalia D'Angelo
Journal:  J Mol Neurosci       Date:  2016-12-20       Impact factor: 3.444

4.  Novel loss of function mutation in KRIT1/CCM1 is associated with distinctly progressive cerebral and spinal cavernous malformations after radiochemotherapy for intracranial malignant germ cell tumor.

Authors:  Alexandra Russo; Marie Astrid Neu; Johanna Theruvath; Bettina Kron; Arthur Wingerter; Silla Hey-Koch; Yasemin Tanyildizi; Joerg Faber
Journal:  Childs Nerv Syst       Date:  2017-05-09       Impact factor: 1.475

5.  Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH).

Authors:  Sean P Polster; Ying Cao; Timothy Carroll; Kelly Flemming; Romuald Girard; Daniel Hanley; Nicholas Hobson; Helen Kim; James Koenig; Janne Koskimäki; Karen Lane; Jennifer J Majersik; Nichol McBee; Leslie Morrison; Robert Shenkar; Agnieszka Stadnik; Richard E Thompson; Joseph Zabramski; Hussein A Zeineddine; Issam A Awad
Journal:  Neurosurgery       Date:  2019-04-01       Impact factor: 4.654

6.  Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice.

Authors:  Luca Bravi; Noemi Rudini; Roberto Cuttano; Costanza Giampietro; Luigi Maddaluno; Luca Ferrarini; Ralf H Adams; Monica Corada; Gwenola Boulday; Elizabeth Tournier-Lasserve; Elisabetta Dejana; Maria Grazia Lampugnani
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-24       Impact factor: 11.205

Review 7.  Cerebral Cavernous Malformation: From Mechanism to Therapy.

Authors:  Daniel A Snellings; Courtney C Hong; Aileen A Ren; Miguel A Lopez-Ramirez; Romuald Girard; Abhinav Srinath; Douglas A Marchuk; Mark H Ginsberg; Issam A Awad; Mark L Kahn
Journal:  Circ Res       Date:  2021-06-24       Impact factor: 23.213

8.  Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation.

Authors:  Miguel Alejandro Lopez-Ramirez; Catherine Chinhchu Lai; Shady Ibrahim Soliman; Preston Hale; Angela Pham; Esau J Estrada; Sara McCurdy; Romuald Girard; Riya Verma; Thomas Moore; Rhonda Lightle; Nicholas Hobson; Robert Shenkar; Orit Poulsen; Gabriel G Haddad; Richard Daneman; Brendan Gongol; Hao Sun; Frederic Lagarrigue; Issam A Awad; Mark H Ginsberg
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 19.456

9.  Beyond multiple mechanisms and a unique drug: Defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies.

Authors:  Saverio Marchi; Eliana Trapani; Mariangela Corricelli; Luca Goitre; Paolo Pinton; Saverio Francesco Retta
Journal:  Rare Dis       Date:  2016-01-25

10.  Phospholipase Cε Modulates Rap1 Activity and the Endothelial Barrier.

Authors:  Peter V DiStefano; Alan V Smrcka; Angela J Glading
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.